Effusion cytology in ovarian cancer: new molecular methods as aids to diagnosis and prognosis (Q35560094)

8 August 2017

1 reference

title

Effusion cytology in ovarian cancer: new molecular methods as aids to diagnosis and prognosis (English)

1 reference

8 August 2017

1 reference

1 reference

Ben Davidson

1

1 reference

8 August 2017

Björn Risberg

2

1 reference

8 August 2017

Reuven Reich

3

1 reference

8 August 2017

Aasmund Berner

4

1 reference

8 August 2017

language of work or name

1 reference

1 September 2003

1 reference

full work available at URL

8 August 2017

https://api.elsevier.com/content/article/PII:S0272271203000581?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0272-2712(03)00058-1

https://api.elsevier.com/content/article/PII:S0272271203000581?httpAccept=text/plain

21 March 2024

1 reference

https://api.crossref.org/works/10.1016/S0272-2712(03)00058-1

Clinics in laboratory medicine

21 March 2024

published in

1 reference

8 August 2017

23

1 reference

8 August 2017

3

1 reference

8 August 2017

729-54, viii

1 reference

8 August 2017

Cancer statistics, 2001

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900058-1

7 January 2021

Relationship between pelvic lymph node involvement and other disease sites in patients with ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900058-1

7 January 2021

Relationship between paraaortic lymph node involvement and intraperitoneal spread in patients with ovarian cancer--a multivariate analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900058-1

7 January 2021

Central nervous system metastases in patients with ovarian carcinoma. A report of 23 cases and a literature review

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900058-1

7 January 2021

Prognostic significance of residual disease in patients with stage IV epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900058-1

7 January 2021

Prognostic factors of stage IV epithelial ovarian cancer: a multicenter retrospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900058-1

7 January 2021

Symptomatology of ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900058-1

7 January 2021

Ovarian cancer stages I and II: predictions and 5-year survival in two decades

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900058-1

7 January 2021

Genesis of ascites in ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900058-1

7 January 2021

Stage IV ovarian cancer: impact of surgical debulking

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900058-1

7 January 2021

Natural history of stage IV epithelial ovarian cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900058-1

7 January 2021

Natural history and prognosis of untreated stage I epithelial ovarian carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900058-1

7 January 2021

Correlation of ascitic fluid cytology with histologic findings before and after treatment of ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900058-1

7 January 2021

The prognostic significance of residual disease, FIGO substage, tumor histology, and grade in patients with FIGO stage III ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900058-1

7 January 2021

The prognostic implication of ascites in advanced-stage ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900058-1

7 January 2021

Identification of prognostic factors in advanced epithelial ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900058-1

7 January 2021

Survival determinants in patients with advanced ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900058-1

7 January 2021

Survival of women with advanced ovarian cancer and complete pathologic response at second-look laparotomy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900058-1

7 January 2021

FIGO stage, histology, histologic grade, age and race as prognostic factors in determining survival for cancers of the female gynecological system: an analysis of 1973-87 SEER cases of cancers of the endometrium, cervix, ovary, vulva, and vagina

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900058-1

7 January 2021

Clinicopathologic variables, operative characteristics, and DNA ploidy in predicting outcome in ovarian epithelial carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900058-1

7 January 2021

A prognostic model for ovarian cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900058-1

7 January 2021

Prognostic factors in extraovarian primary peritoneal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900058-1

7 January 2021

Diagnostic problems in serous effusions

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900058-1

7 January 2021

Markers for metastatic adenocarcinoma in serous effusion specimens

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900058-1

7 January 2021

Complementary value of five carcinoma markers for the diagnosis of malignant mesothelioma, adenocarcinoma metastasis, and reactive mesothelium in serous effusions

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900058-1

7 January 2021

Utility of BER-EP4 in the diagnosis of adenocarcinoma in effusions: an immunocytochemical study of 232 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900058-1

7 January 2021

Detection of cancer cells in effusions from patients diagnosed with gynaecological malignancies. Evaluation of five epithelial markers

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900058-1

7 January 2021

The role of desmin and N-cadherin in effusion cytology: a comparative study using established markers of mesothelial and epithelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900058-1

7 January 2021

Comparison of antigen expression on fresh and cultured ascites cells and on solid tumors of patients with epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900058-1

7 January 2021

Analysis of antigen expression at multiple tumor sites in epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900058-1

7 January 2021

Carbohydrate antigen expression in primary tumors, metastatic lesions, and serous effusions from patients diagnosed with epithelial ovarian carcinoma: evidence of up-regulated Tn and Sialyl Tn antigen expression in effusions

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900058-1

7 January 2021

E-cadherin and alpha-, beta-, and gamma-catenin protein expression is up-regulated in ovarian carcinoma cells in serous effusions

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900058-1

7 January 2021

Use of E-cadherin and CD44 aids in the differentiation between reactive mesothelial cells and carcinoma cells in pelvic washings

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900058-1

7 January 2021

Differential expression of CD44s and CD44v3-10 in adenocarcinoma cells and reactive mesothelial cells in effusions

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900058-1

7 January 2021

WT1, estrogen receptor, and progesterone receptor as markers for breast or ovarian primary sites in metastatic adenocarcinoma to body fluids

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900058-1

7 January 2021

Flow cytometric immunophenotyping of serous effusions and peritoneal washings: comparison with immunocytochemistry and morphological findings

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900058-1

7 January 2021

Detection of monocyte/macrophage cell populations in effusions: a comparative study using flow cytometric immunophenotyping and immunocytochemistry

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900058-1

7 January 2021

Detection of malignant epithelial cells in effusions using flow cytometric immunophenotyping: an analysis of 92 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900058-1

7 January 2021

Specific association of human telomerase activity with immortal cells and cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900058-1

7 January 2021

Telomerase activity in human cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900058-1

7 January 2021

Applications of the telomerase assay in peritoneal washing fluids

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900058-1

7 January 2021

Telomerase activity in benign and malignant cytologic fluids

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900058-1

7 January 2021

Pitfalls in TRAP assay in routine detection of malignancy in effusions

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900058-1

7 January 2021

p53 immunohistochemistry for distinguishing reactive mesothelium from low grade ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900058-1

7 January 2021

Incidence of double minutes, cytogenetic equivalents of gene amplification, in human carcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900058-1

7 January 2021

Detection of chromosomal aberrations in tumor cells and tumor infiltrating lymphocytes by molecular cytogenetics in patients with gynecological cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900058-1

7 January 2021

Chromosome aberrations in nine patients with ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900058-1

7 January 2021

Changes of chromosomes 1, 3, 6, and 11 in metastatic effusions arising from breast and ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900058-1

7 January 2021

New functions for the matrix metalloproteinases in cancer progression

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900058-1

7 January 2021

Production of extracellular matrix-degrading proteinases by primary cultures of human epithelial ovarian carcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900058-1

7 January 2021

Increased matrix metalloproteinase-9 activity in human ovarian cancer cells cultured with conditioned medium from human peritoneal tissue.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900058-1

7 January 2021

Ovarian carcinoma cells in serous effusions show altered MMP-2 and TIMP-2 mRNA levels

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900058-1

7 January 2021

Expression of membrane-type 1, 2, and 3 matrix metalloproteinases messenger RNA in ovarian carcinoma cells in serous effusions

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900058-1

7 January 2021

E-cadherin mediated adhesion system in cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900058-1

7 January 2021

Inactivation of the E-cadherin-mediated cell adhesion system in human cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900058-1

7 January 2021

Mutations of the E-cadherin gene in human gynecologic cancers.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900058-1

7 January 2021

beta-catenin expression pattern in stage I and II ovarian carcinomas : relationship with beta-catenin gene mutations, clinicopathological features, and clinical outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900058-1

7 January 2021

The role of integrins in tumorigenesis and metastasis.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900058-1

7 January 2021

Role of integrins in cell invasion and migration

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900058-1

7 January 2021

Biology of tumor cell invasion: interplay of cell adhesion and matrix degradation

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900058-1

7 January 2021

CD44 and beta1 integrin mediate ovarian carcinoma cell adhesion to peritoneal mesothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900058-1

7 January 2021

Beta1-integrins partly mediate binding of ovarian cancer cells to peritoneal mesothelium in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900058-1

7 January 2021

Expression and Function of β1 and αvβ3 Integrins in Ovarian Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900058-1

7 January 2021

AlphaV- and beta1-integrin subunits are commonly expressed in malignant effusions from ovarian carcinoma patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900058-1

7 January 2021

EMMPRIN (extracellular matrix metalloproteinase inducer) is a novel marker of poor outcome in serous ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900058-1

7 January 2021

Generation of monoclonal antibodies to integrin-associated proteins. Evidence that alpha3beta1 complexes with EMMPRIN/basigin/OX47/M6

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900058-1

7 January 2021

Caveolin, a protein component of caveolae membrane coats

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900058-1

7 January 2021

Caveolae: where incoming and outgoing messengers meet

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900058-1

7 January 2021

Caveolins, a family of scaffolding proteins for organizing "preassembled signaling complexes" at the plasma membrane

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900058-1

7 January 2021

Molecular genetics of the caveolin gene family: implications for human cancers, diabetes, Alzheimer disease, and muscular dystrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900058-1

7 January 2021

Genes encoding human caveolin-1 and -2 are co-localized to the D7S522 locus (7q31.1), a known fragile site (FRA7G) that is frequently deleted in human cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900058-1

7 January 2021

Sequence and detailed organization of the human caveolin-1 and -2 genes located near the D7S522 locus (7q31.1). Methylation of a CpG island in the 5' promoter region of the caveolin-1 gene in human breast cancer cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900058-1

7 January 2021

Downmodulation of caveolin-1 expression in human ovarian carcinoma is directly related to alpha-folate receptor overexpression

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900058-1

7 January 2021

Caveolin-1 expression in ovarian carcinoma is MDR1 independent

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900058-1

7 January 2021

Expression of FHIT in primary cultures of human epithelial ovarian tumors and malignant ovarian ascites.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900058-1

7 January 2021

Neurotrophic factors and their receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900058-1

7 January 2021

Signal transduction by the neurotrophin receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900058-1

7 January 2021

Immunohistochemical analysis of TrkA neurotrophin receptor expression in human non-neuronal carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900058-1

7 January 2021

The implications of angiogenesis for the biology and therapy of cancer metastasis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900058-1

7 January 2021

Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900058-1

7 January 2021

Vascular permeability factor, an endothelial cell mitogen related to PDGF

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900058-1

7 January 2021

Molecular and biological characterization of fibroblast growth factor, an angiogenic factor which also controls the proliferation and differentiation of mesoderm and neuroectoderm derived cells

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900058-1

7 January 2021

Interleukin-8 as a macrophage-derived mediator of angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900058-1

7 January 2021

The chemotactic cytokine interleukin-8--a cyst fluid marker for malignant epithelial ovarian cancer?

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900058-1

7 January 2021

Vascular endothelial growth factor in the sera and effusions of patients with malignant and nonmalignant disease

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900058-1

7 January 2021

Markedly elevated levels of vascular endothelial growth factor in malignant ascites

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900058-1

7 January 2021

Expression of vascular endothelial growth factor and its receptors flt and KDR in ovarian carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900058-1

7 January 2021

Interleukin-8 and vascular endothelial growth factor mRNA and protein levels are down-regulated in ovarian carcinoma cells in serous effusions

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900058-1

7 January 2021

Differential expression of cytokine transcripts in human epithelial ovarian carcinoma by solid tumour specimens, peritoneal exudate cells containing tumour, tumour-infiltrating lymphocyte (TIL)-derived T cell lines and established tumour cell lines.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900058-1

7 January 2021

Ascitic interleukin-12 is an independent prognostic factor in ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900058-1

7 January 2021

Colony-stimulating factor-1 in primary ascites of ovarian cancer is a significant predictor of survival.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900058-1

7 January 2021

The significance of urokinase- type plasminogen activator, its inhibitors, and its receptor in ascites of patients with epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900058-1

7 January 2021

Clinical significance of serum and ascitic p53 autoantibodies in epithelial ovarian carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900058-1

7 January 2021

Expression of cell cycle proteins in ovarian carcinoma cells in serous effusions-biological and prognostic implications

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900058-1

7 January 2021

Ets-1 mRNA expression in effusions of serous ovarian carcinoma patients is a marker of poor outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900058-1

7 January 2021

Expression of CD44 in effusions of patients diagnosed with serous ovarian carcinoma--diagnostic and prognostic implications

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900058-1

7 January 2021

Ras gene activation in malignant cells of human ovarian carcinoma peritoneal fluids

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900058-1

7 January 2021

Ovarian epithelial carcinoma tyrosine phosphorylation, cell proliferation, and ezrin translocation are stimulated by interleukin 1alpha and epidermal growth factor

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900058-1

7 January 2021

Expression and mutation of p53 in tumor effusion cells of patients with ovarian carcinoma: response to cisplatin-based chemotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900058-1

7 January 2021

hMSH2 and GTBP expression in advanced stage epithelial ovarian cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900058-1

7 January 2021

Taxol-resistant epithelial ovarian tumors are associated with altered expression of specific beta-tubulin isotypes

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2803%2900058-1

7 January 2021

The role of lymphatic obstruction in the formation of ascites in a murine ovarian carcinoma

11

1 reference

https://api.crossref.org/works/10.1016/S0272-2712(03)00058-1

Role of cytoreductive surgical treatment in the management of advanced ovarian cancer

21 March 2024

12

1 reference

https://api.crossref.org/works/10.1016/S0272-2712(03)00058-1

Cytohistologic correlation of peritoneal washing cytology in gynecologic disease

21 March 2024

31

1 reference

https://api.crossref.org/works/10.1016/S0272-2712(03)00058-1

Peritoneal washings in ovarian tumors. Potential sources of error in cytologic diagnosis

21 March 2024

33

1 reference

https://api.crossref.org/works/10.1016/S0272-2712(03)00058-1

Cytology of peritoneal washings in gynecologic patients. Diagnostic criteria and pitfalls

21 March 2024

34

1 reference

https://api.crossref.org/works/10.1016/S0272-2712(03)00058-1

Immunocytochemical differentiation of reactive mesothelial cells and adenocarcinoma cells in serous effusions with the use of carcinoembryonic antigen and fibronectin

21 March 2024

40

1 reference

https://api.crossref.org/works/10.1016/S0272-2712(03)00058-1

Carcinoma of ovarian and other origins in effusions. Immunocytochemical study with a panel of monoclonal antibodies

21 March 2024

41

1 reference

https://api.crossref.org/works/10.1016/S0272-2712(03)00058-1

Clinical utility of the immunocytochemical detection of p53 protein in cytological specimens

21 March 2024

63

1 reference

https://api.crossref.org/works/10.1016/S0272-2712(03)00058-1

Cytogenetic and cell cycle studies in metastatic cells from ovarian carcinomas

21 March 2024

65

1 reference

https://api.crossref.org/works/10.1016/S0272-2712(03)00058-1

Membrane-type matrix metalloproteinase expression and matrix metalloproteinase-2 activation in primary human ovarian epithelial carcinoma cells

21 March 2024

73

1 reference

https://api.crossref.org/works/10.1016/S0272-2712(03)00058-1

Fibronectin secretion from human peritoneal tissue induces Mr 92,000 type IV collagenase expression and invasion in ovarian cancer cell lines

21 March 2024

75

1 reference

https://api.crossref.org/works/10.1016/S0272-2712(03)00058-1

Two distinct patterns of peritoneal involvement shown by in vitro and in vivo ovarian cancer dissemination models

21 March 2024

87

1 reference

https://api.crossref.org/works/10.1016/S0272-2712(03)00058-1

Sequence and detailed organization of the human caveolin-1 and -2 genes located near the D7S522 locus (7q31.1)

21 March 2024

100

1 reference

https://api.crossref.org/works/10.1016/S0272-2712(03)00058-1

Expression and activation of the nerve growth factor receptor TrkA in serous ovarian carcinoma

21 March 2024

108

1 reference

https://api.crossref.org/works/10.1016/S0272-2712(03)00058-1

The fibroblast growth factor family

21 March 2024

113

1 reference

https://api.crossref.org/works/10.1016/S0272-2712(03)00058-1

Angiogenic protein expression in advanced epithelial ovarian cancer

21 March 2024

117

1 reference

https://api.crossref.org/works/10.1016/S0272-2712(03)00058-1

Overexpression of epithelial macrophage colony-stimulating factor (CSF-1) and CSF-1 receptor: a poor prognostic factor in epithelial ovarian cancer, contrasted with a protective effect of stromal CSF-1

21 March 2024

126

1 reference

https://api.crossref.org/works/10.1016/S0272-2712(03)00058-1

21 March 2024

Identifiers

1 reference

8 August 2017

1 reference